Exact Mass: 319.1202

Exact Mass Matches: 319.1202

Found 66 metabolites which its exact mass value is equals to given mass value 319.1202, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tryptophyl-Aspartate

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}butanedioate

C15H17N3O5 (319.1168)


Tryptophyl-Aspartate is a dipeptide composed of tryptophan and aspartate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Aspartyl-Tryptophan

3-Amino-3-{[1-carboxy-2-(1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}propanoate

C15H17N3O5 (319.1168)


Aspartyl-Tryptophan is a dipeptide composed of aspartate and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

4-Hydroxy-5-[3-[(1-methylcyclohexyl)methoxy]phenyl]-3H-1,3-thiazol-2-one

4-hydroxy-5-{3-[(1-methylcyclohexyl)methoxy]phenyl}-2,3-dihydro-1,3-thiazol-2-one

C17H21NO3S (319.1242)


   
   

6-methoxy-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-naphthalen-1-imine

6-methoxy-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-naphthalen-1-imine

C18H16F3NO (319.1184)


   

4,5-Dehydroguadiscine

4,5-Dehydroguadiscine

C20H17NO3 (319.1208)


   

1-N-beta-D-ribofuranosylmakaluvamine I|N-1-beta-D-ribofuranosylmakalucamine I|N-1-beta-D-ribofuranosylmakaluvamine I

1-N-beta-D-ribofuranosylmakaluvamine I|N-1-beta-D-ribofuranosylmakalucamine I|N-1-beta-D-ribofuranosylmakaluvamine I

C15H17N3O5 (319.1168)


   

Oidioperazine B

Oidioperazine B

C15H17N3O5 (319.1168)


   
   
   
   
   
   
   
   
   

Asp-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]butanedioic acid

C15H17N3O5 (319.1168)


A dipeptide formed from L-alpha-aspartyl and L-tryptophan residues.

   

TRP-Asp

3-amino-3-{[1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C15H17N3O5 (319.1168)


A dipeptide formed from L-tryptophan and L-aspartic acid residues.

   
   

ETHYL5-CHLOROTHIOPHENE-2-CARBOXLATE

ETHYL5-CHLOROTHIOPHENE-2-CARBOXLATE

C17H21NO3S (319.1242)


   

(S)-(+)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAM&

(S)-(+)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAM&

C20H17NO3 (319.1208)


   

2-[4-[2-nitro-4-(trifluoromethyl)phenyl]piperazino]-1-ethanol

2-[4-[2-nitro-4-(trifluoromethyl)phenyl]piperazino]-1-ethanol

C13H16F3N3O3 (319.1144)


   

(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-phenylacetic acid

(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-phenylacetic acid

C15H17N3O5 (319.1168)


   

4-Aminobenzo-15-crown-5 hydrochloride

4-Aminobenzo-15-crown-5 hydrochloride

C14H22ClNO5 (319.1186)


   

NAPHTHOL AS-D ACETATE

NAPHTHOL AS-D ACETATE

C20H17NO3 (319.1208)


   

2-[4-(4-hydroxybut-2-ynyl)piperazin-1-yl]-3-nitrobenzoic acid

2-[4-(4-hydroxybut-2-ynyl)piperazin-1-yl]-3-nitrobenzoic acid

C15H17N3O5 (319.1168)


   

dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate

dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate

C13H21NO8 (319.1267)


   

Y-27632 dihydrochloride

Y-27632 dihydrochloride

C14H23Cl2N3O (319.1218)


   

(E)-P,P-diphenyl-N-(1-phenylethylidene)phosphinic amide

(E)-P,P-diphenyl-N-(1-phenylethylidene)phosphinic amide

C20H18NOP (319.1126)


   

(1-(tert-Butoxycarbonyl)-7-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-7-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.1227)


   

[4-methoxycarbonyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[4-methoxycarbonyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C15H18BNO6 (319.1227)


   

(1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.1227)


   

1-Boc-4-(4-Bromobutyl)piperidine

1-Boc-4-(4-Bromobutyl)piperidine

C14H26BrNO2 (319.1147)


   

(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.1227)


   

Sumanirole Maleate

Sumanirole Maleate

C15H17N3O5 (319.1168)


Sumanirole maleate (U-95666E; PNU-95666E) is a highly selective D2 receptor full agonist with an ED50 of about 46 nM. Sumanirole plays an important role in the research of Parkinson's disease and restless leg syndrome[1].

   

(R)-(-)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAMI C ACID

(R)-(-)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAMI C ACID

C20H17NO3 (319.1208)


   

4,4,4-Methanetriyltribenzonitrile

4,4,4-Methanetriyltribenzonitrile

C22H13N3 (319.1109)


   

3-O-methylentacapone

3-O-methylentacapone

C15H17N3O5 (319.1168)


   

5-(2-Fluorophenyl)-N-(Pyridin-4-Ylmethyl)pyrazolo[1,5-A]pyrimidin-7-Amine

5-(2-Fluorophenyl)-N-(Pyridin-4-Ylmethyl)pyrazolo[1,5-A]pyrimidin-7-Amine

C18H14FN5 (319.1233)


   

6-(2-Fluorophenyl)-N-(Pyridin-3-Ylmethyl)imidazo[1,2-A]pyrazin-8-Amine

6-(2-Fluorophenyl)-N-(Pyridin-3-Ylmethyl)imidazo[1,2-A]pyrazin-8-Amine

C18H14FN5 (319.1233)


   

{2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid

{2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid

C15H17N3O5 (319.1168)


   

(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate

(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate

C17H19O6- (319.1182)


   

6-Methyl-5-[3-(3-nitrophenoxy)propoxy]pyrimidine-2,4-diamine

6-Methyl-5-[3-(3-nitrophenoxy)propoxy]pyrimidine-2,4-diamine

C14H17N5O4 (319.128)


   
   

1-[[(1,5-Dimethyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxyphenyl)thiourea

1-[[(1,5-Dimethyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxyphenyl)thiourea

C14H17N5O2S (319.1103)


   

3,5-dimethyl-1H-pyrrole-2,4-dicarboxylic acid O4-ethyl ester O2-[(2-fluorophenyl)methyl] ester

3,5-dimethyl-1H-pyrrole-2,4-dicarboxylic acid O4-ethyl ester O2-[(2-fluorophenyl)methyl] ester

C17H18FNO4 (319.122)


   

N-(4-fluorophenyl)-1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine

N-(4-fluorophenyl)-1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine

C18H14FN5 (319.1233)


   

1-(4-Methoxyanilino)-3-(4-methoxyphenyl)sulanylpropan-2-ol

1-(4-Methoxyanilino)-3-(4-methoxyphenyl)sulanylpropan-2-ol

C17H21NO3S (319.1242)


   
   
   
   
   
   
   

N-acetylmethionylglutamine

N-acetylmethionylglutamine

C12H21N3O5S (319.1202)


   

(N-Trifluoroacetylamino)methylphosphonic acid dibutyl ester

(N-Trifluoroacetylamino)methylphosphonic acid dibutyl ester

C11H21F3NO4P (319.116)


   

3-Methyl-4-phenacyl-1-para-tolyl-3-pyrroline-2,5-dione

3-Methyl-4-phenacyl-1-para-tolyl-3-pyrroline-2,5-dione

C20H17NO3 (319.1208)


   

Mycophenolate

Mycophenolate

C17H19O6 (319.1182)


A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of mycophenolic acid.

   

(2z)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2z)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.1242)


   

n-(4-{[3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

n-(4-{[3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.1242)


   

10-amino-2-[(3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-amino-2-[(3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C15H17N3O5 (319.1168)


   

(2e)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2e)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.1242)


   

(2e)-n-(4-{[(2z)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2e)-n-(4-{[(2z)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.1242)


   

16-methoxy-13,13-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaene

16-methoxy-13,13-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaene

C20H17NO3 (319.1208)


   

3,5-dihydroxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

3,5-dihydroxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

C13H21NO8 (319.1267)


   

5,6-dihydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methoxy-3h-pyrazin-2-one

5,6-dihydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methoxy-3h-pyrazin-2-one

C15H17N3O5 (319.1168)